Interferons are important in regulating cell growth and dierentiation, immune function and initiating anti-viral responses. While the pleotrophic actions of interferons have been well documented, the molecular mechanisms underpinning their biological eects have not been fully characterized. IFI 16 is a member of the interferoninducible HIN-200 family of nuclear proteins, which we have recently shown can function as a potent transcriptional repressor. A murine member of the HIN-200 family, p202, can indirectly interact with p53 via the p53 binding protein (p53bp) and inhibit p53-mediated transcriptional activation. The binding activity of p202 to p53bp was shown to require the conserved MFHATVAT motif present in all 200 amino acid repeat regions of HIN-200 proteins. Given that IFI 16 contains two MFHATVAT motifs, we sought to determine whether IFI 16 may form a complex with p53 and if so to ascertain the functional signi®cance of this interaction. We demonstrate that IFI 16 can directly bind to the Cterminal region of p53 and augment p53-mediated transcriptional activation without altering the steady state levels of p53. Thus, in addition to its ability to directly regulate gene expression, IFI 16 can alsoIntroduction Interferons (IFNs) play an important role in human biology by regulating cell growth and dierentiation, immune function and inhibiting viral replication (Stark et al., 1998) . Binding of type I (a and b) and type II (g) IFNs to their cognate cell surface receptors initiates a series of intracellular signalling cascades resulting in the activation of speci®c target genes (Darnell et al., 1994) . The protein products of these genes directly or indirectly mediate the necessary biological response. While there are hundreds of cellular genes that can be induced following IFN stimulation, the molecular and biological functions of many of these gene products are often not known.
Human and mouse members of the HIN-200 (Hematopoietic Interferon-inducible Nuclear proteins with a 200 amino acid repeat) family are positively regulated by type I and II interferons (Dawson and Trapani, 1996; Lengyel et al., 1995) . The human HIN-200 members include IFI 16 (Trapani et al., 1992) , the myeloid nuclear dierentiation antigen (MNDA) (Burrus et al., 1992; Duhl et al., 1989) and AIM-2 (Absent In Melanoma) (DeYoung et al., 1997) while the mouse members include p202 (Choubey et al., 1989) , p203 (Gribaudo et al., 1997) , p204 (Choubey et al., 1989) and D3 (Tannenbaum et al., 1993) . proteins share common structural and biochemical properties including the presence of at least one common 200 amino acid repeat motif of unknown function, the ability to bind double stranded DNA, and all are localized to the nucleus (Dawson and Trapani, 1996; Lengyel et al., 1995; Landolfo et al., 1998; Johnstone and Trapani, 1999) .
Recently, there have been a number of reports examining possible molecular and cellular functions for HIN-200 proteins. Some members of the family have been demonstrated to modulate transcription and the best studied protein to date is p202 which can bind to a number of transcription factors including NF-kB (Min et al., 1996) , AP-1 (c-Jun/c-Fos) (Min et al., 1996) , MyoD (Datta et al., 1998) , p53 (via its interaction with p53-binding protein 1 (p53bp)) and E2F (E2F-1/DP-1, E2F-4/DP-1) Choubey and Gutterman, 1997) . Binding of p202 to these proteins results in a loss of their transcriptional regulatory activities and inhibits the binding of E2F and AP-1 to speci®c DNA elements (Min et al., 1996; Choubey et al., 1996; Choubey and Gutterman, 1997) . Expression of p202 correlated with a decrease in endogenous levels of MyoD RNA and with a loss of transcriptional activity mediated by transfected MyoD (Datta et al., 1998) . The manner by which p202 regulates transactivation mediated by NF-kB, p53 and transfected MyoD has not yet been determined. The related mouse protein p204 also has transcription regulatory properties as it can bind to and inhibit the DNA binding and transcriptional activity of the ribosomal RNA-speci®c factor UBF1 (Liu et al., 1999) . In contrast, the human HIN-200 protein MNDA can augment transcriptional activities of YY1 by stimulating the binding of YY1 to its cognate DNA element (Xie et al., 1998) . We have shown that IFI 16 can itself function as a transcriptional repressor when bound upstream of a functional promoter (Johnstone et al., 1998a) . We have mapped the repression domains of IFI 16 to either of the two homologous 200 amino acid motifs present in the molecule and the repression function of other HIN-200 proteins is currently under investigation.
Overexpression of murine p202 and p204 correlates with a reduction of cell growth as a result of delayed transition through the G1/S checkpoint of the cell cycle Lembo et al., 1995 Lembo et al., , 1998 Yan et al., 1999) . The molecular mechanisms involved in cell cycle regulation by p202 and p204 have yet to be elucidated, however both proteins can physically interact with the retinoblastoma tumour suppressor protein, pRb, which is directly involved in regulating the G1/S cell cycle checkpoint Liu et al., 1999) . It has therefore been hypothesized that HIN-200 proteins may regulate the cell cycle via their interaction with pRb. In addition, as p202 can also interact with p53 and E2F and aect their transcriptional activities, it is possible that regulation of the G1/S checkpoint may occur directly via the E2F interaction, or indirectly by aecting the transactivation activities of p53. It should be noted, however, that functional p53 is not necessary for p202-induced suppression of cell proliferation as overexpression of p202 in p53-null cells results in an increase in the levels of p21 waf1/Cip1 CDK inhibitor and retardation of cell proliferation . Surprisingly, inhibition of endogenous p202 production did not result in cell proliferation but rather increased the susceptibility of these cells to apoptosis (Koul et al., 1998) .
Endogenous IFI 16 and p53 were shown to interact in vivo using immunoprecipitation/Western analysis and colocalized in the nucleus by confocal microscopy. However, unlike p202, IFI 16 could directly interact with puri®ed recombinant p53 indicating that p53bp is not required for this interaction. We have mapped the p53-binding domain of IFI 16 to the N-terminal 200 amino acid repeat (the`A' repeat), while the C-terminal B' repeat which also contains an MFHATVAT motif did not bind p53. The IFI 16-binding region of p53 was mapped to the C-terminal 30 amino acids of the protein. p53 has been shown to be activated following modi®cation of the C-terminus by acetylation (Gu and Roeder, 1997) , phosphorylation (Hupp et al., 1992) , mutation (Hupp et al., 1992; Marston et al., 1998) and glycosylation (Shaw et al., 1996) . It was recently demonstrated that binding of the small ubiquitin-like cellular protein SUMO-1 to the C-terminus of p53 increased the transcriptional activation activity of p53 through an unknown mechanism (Rodriguez et al., 1999) . Interestingly we now demonstrate that expression of IFI 16 also results in augmented transcriptional activation mediated by p53. In a human T cell line expressing wild type, active p53 and endogenous IFI 16, an anti-IFI 16 monoclonal antibody decreased formation of a complex consisting of p53 and an oligonucleotide containing a consensus p53 binding sequence. These data indicate that IFI 16 can interact with p53 and enhance the transcriptional activation function of p53.
Results

In vivo interaction between IFI 16 and p53
Previous studies have shown that the murine p202 protein can interact with p53bp and inhibit p53-mediated transcriptional activation . A wild type MFHATVAT motif within the conserved 200 amino acid repeat region of p202 was necessary for this interaction. Given that IFI 16 also contains two 200 amino acid repeats with a precisely conserved MFHATVAT sequence we sought to determine whether IFI 16 may directly or indirectly interact with p53. Daudi cells constitutively express both IFI 16 and p53. Confocal microscopy of Daudi cells stained simultaneously with both rabbit polyclonal anti-IFI 16 and mouse monoclonal anti-p53 antibodies demonstrated that both molecules were predominantly nuclear and colocalized within the nucleoplasm ( Figure  1a ). Co-immunoprecipitation experiments were performed with Daudi nuclear lysates using monoclonal antibodies against IFI 16, p53 or a control antibody which detects the yeast GAL4 transcription factor DNA binding domain (Figure 1b 
Direct interaction between IFI 16 and p53
To map the region(s) within IFI 16 that interacted with p53, in vitro binding assays were performed using in vitro transcribed/translated wild type p53 and wild type or truncated IFI 16 fused to GST (Figure 2a ). The various puri®ed recombinant GST-IFI 16 proteins and control GST-p53 and GST alone are shown in Figure  2a The reciprocal in vitro binding assay was performed using GST fused to wild type p53 or various p53 deletion mutants and radiolabelled in vitro transcribed/ translated IFI 16, to determine the region(s) of p53 necessary for binding to IFI 16. The GST fusion proteins used in the study are shown in Figure 2b It has previously been shown that the interaction between p202 and p53 is indirect, and mediated by p53bp . In order to determine whether IFI 16 and p53 can interact directly, recombinant puri®ed p53 and IFI 16 were used in in vitro binding assays (Figure 2c ). The GST polypeptide was cleaved from the GST-p53 fusion protein using the PreScission protease resulting in two major proteins of approximately 53 and 51 kD ( Figure 2c , lane 3). Recombinant puri®ed p53 was incubated with GST-IFI 16 or GST alone bound to sepharose, washed and bound p53 resolved by SDS ± PAGE and detected by Western blot using an anti-p53 mAb. Recombinant p53 directly associated with GST-IFI 16 ( Figure 2c , lane 1) and did not bind GST alone. Interestingly IFI 16 preferentially interacted with the larger, presumably intact form of recombinant p53. waf1/Cip1 (El-Deiry et al., 1993) and the proapoptotic Bcl-2 family member Bax (Miyashita and Reed, 1995) . In order to determine the functional eect of IFI 16 binding to p53 we used the CAT reporter plasmid p13RE DIST/PROX containing consensus p53 sites upstream and downstream of the CAT gene (Stenger et al., 1994) . 293 cells were cotransfected with p13RE
DIST/PROX and a p53 expression plasmid resulting in a threefold increase in CAT activity compared to basal levels ( Figure 3a, lanes 1 ± 3) . 293 cells express little or no IFI 16 and low levels of wild type p53 (Matsuzawa et al., 1998) but are transformed with the Ad5 adenovirus (Graham et al., 1977) and contain the E1B/55 kD viral protein which binds to and functionally inhibits p53 (Yew and Berk, 1992) . Addition of increasing amounts of full length IFI 16 resulted in a dose-dependent increase in p53-mediated transcriptional activation (Figure 3a , lanes 5 and 6) compared to that seen with the control empty expression vector (Figure 3a , lanes 7 and 8). p53 in the presence or absence of IFI 16 had no eect on transcriptional activity of the pE1bTATA control CAT reporter which does not contain p53 binding sites (Figure 3a , lanes 9 ± 12.
To correlate binding of IFI 16 to p53 with augmentation of p53-mediated transactivation, we performed similar cotransfection/CAT assays with IFI 16 constructs expressing the 200 amino acid A repeat and therefore contains the putative p53 binding domain [IFI 16 (1 ± 729) We also tested for augmentation of p53-mediated transcriptional activation by IFI 16 using the pWWLuc reporter plasmid. This plasmid contains the 2.4 kb 5' region from p21 Waf1/Cip1 which has been shown to be a functionally important target gene for p53 (El-Diery et al., 1993) . As expected, cotransfection of the pCMVp53 expression plasmid with pWWLuc resulted in an increase in luciferase activity (Figure 3d, lanes 1 and 2) . However, deletion of the p53 binding site within the p21 Waf1/Cip promoter resulted in a loss of p53-responsiveness (Figure 3d , lanes 9 and 10). As was seen with the p13RE DIST/PROX plasmid, coexpression of IFI 16 augmented p53-mediated transcriptional activation of the pWWLuc reporter in a dose-dependent manner (Figure 3d , lanes 5 and 6).
Mechanism of augmented p53-mediated transactivation by IFI 16
We sought to determine the manner in which binding of IFI 16 to p53 results in an increase in p53-mediated transcriptional activation. One possible mechanism is that IFI 16 binds to p53 and stabilizes the molecule thereby increasing p53 steady state levels. We tested this by transfecting IFI 16, p53, or both IFI 16 and p53 into 293 cells and performing Western blot analyses on nuclear extracts (Figure 4a ). Coexpression of IFI 16 and p53 did not alter the expression levels of transfected p53, 24 or 48 h after transfection ( Figure  4a , lanes 2 and 3, data not shown). In addition, expression of wild type p53 had no appreciable aect on expression of transfected IFI 16 (Figure 4a , lanes 1 and 2). These data indicate that IFI 16 does not aect the steady state levels of p53 and likewise p53 does not aect the expression levels of IFI 16. We next tested whether IFI 16 and p53 can interact while p53 is bound to DNA. Gel shift assays were performed using double stranded oligonucleotides derived from the p21 waf1/Cip1 promoter containing wild type p53 binding sites (wtp53) and nuclear extracts from Molt-4 T cells which constitutively express both IFI 16 and minimal amounts of wild type p53. A speci®c protein DNA complex was observed with labelled wild type p53 oligonucleotide that could be competed with a 500-fold excess of cold wtp53 but could not be competed with mutp53 oligonucleotides containing mutations in the p53 binding sequences (Gu and Roeder, 1997) . Addition of a monoclonal antibody speci®c for IFI 16 resulted in a dose-dependent decrease in the speci®c DNA protein signal while addition of an isotype control monoclonal antibody had no eect. These data indicate that p53 can bind to DNA in the presence of IFI 16 and that addition of an anti-IFI 16 monoclonal antibody results in a loss of p53 DNA binding.
Discussion
We have demonstrated herein that IFI 16 and p53 can interact in vitro and in vivo. Binding of the related murine HIN-200 protein p202 to p53bp was shown to depend on the presence of a wild type amino acid sequence MFHATVAT that is highly conserved in all HIN-200 proteins and is found within the common 200 amino acid repeat regions . Surprisingly, only the 200 amino acid A repeat of IFI 16 could interact with p53 even though both A and B 200 amino acid repeats contain identical MFHATVAT mutants were expressed in bacteria fused to GST and recombinant proteins puri®ed by column chromatography. The recombinant puri®ed GST fusion proteins used in the study are shown in the top panel. In vitro translated, sequences. This indicates that the mechanism of interaction between IFI 16 and p53 may be dierent to that identi®ed for the binding of p202 to p53. This hypothesis was further strengthened by the ®nding that recombinant puri®ed IFI 16 could directly interact in vitro with GST-p53. This indicates that in comparison to p202, which requires p53bp to enable interaction with p53, IFI 16 and p53 can associate directly. It is still possible however, that in vivo, other proteins can interact with p53 and IFI 16 to form higher order multi-protein complexes. The C-terminal 33 amino acids were identi®ed as being the region of p53 necessary and sucient for interaction with IFI 16. Posttranslational modi®cation or binding of other cellular proteins to this region of p53 has been demonstrated to modulate the DNA binding and DIST/PROX was co-transfected with pCMV-p53 and increasing amounts of pRcCMV-IFI 16 (1 ± 729), (lanes 7 and 8), pRcCMV-IFI 16 (1 ± 153) (lanes 9 and 10), pRcCMV-IFI 16 (1 ± 476) (lanes 11 and 12), or with pRcCMV alone (lanes 13 and 14) . The amounts of transfected plasmids are indicated in the table below. Results for all CAT assays represent the means and standard deviations from at least three independent transfections and CAT assays. Waf1/Cip1 5' promoter region (p53 responsive) or control pDMLuc (p53 non-responsive) reporter plasmids. Expression plasmids for p53, and/or IFI 16 or empty expression vector, were cotransfected into the cells. As a control for transfection eciency, the pSVbgal was used and b-galactosidase assays were determined. Luciferase activities were determined in aliquots corresponding to equal amounts of b-galactosidase activities. The amounts of transfected plasmids are indicated in the table below transcriptional activation properties of p53 (Hupp et al., 1992; Shaw et al., 1996; Gu and Roeder, 1997; Rodriguez et al., 1999) . We therefore sought to determine the functional consequence of IFI 16 interacting with p53. We used the previously described p13RE
DIST/PROX (Stenger et al., 1994) and pWWLuc (El-Diery et al., 1993) reporter constructs containing consensus p53 binding sites to determine the eect of IFI 16 on p53-mediated transcriptional activation. IFI 16 caused a dose-dependent increase in p53-mediated transactivation and a correlation between binding of IFI 16 to p53 and modulation of p53-mediated transactivation was observed.
What then is the mechanism by which IFI 16 aects p53 transcriptional activity? p53 has a short in vivo half life and is target for ubiquitin-mediated degradation by cellular proteins such as MDM2 (Fuchs et al., 1998) and viral proteins such as the human papillomavirus protein E6 (Schener et al., 1993) . We therefore sought to determine whether expression of IFI 16 correlated with an increase in steady state levels of p53. Coexpression of IFI 16 with p53 did not increase the expression levels of p53 indicating that IFI 16 did not stabilize p53. However in DNA/protein gel shift assays, addition of an anti-IFI 16 monoclonal antibody inhibited speci®c binding of p53 to DNA while addition of a control, isotype-matched antibody had no eect. The mechanism underlying this ®nding remains unclear. It is possible that binding of IFI 16 to the C-terminal region of p53 in Molt-4 cells is necessary for p53 to bind DNA with high anity. Addition of an anti-IFI 16 monoclonal antibody could either (i) directly disrupt the interaction between p53 and IFI 16, (ii) usurp IFI 16 away from p53, (iii) alter the conformation of the IFI 16/p53 complex and thereby either sterically hinder protein-DNA interactions or (iv) initiate a change in p53 structure that is not conducive to DNA binding. Whatever the mechanism, these data indicate that binding of IFI 16 to p53 may be important for binding of p53 to DNA which translates to an increase in the transcriptional activation function of p53.
The physiological signi®cance of the IFI 16/p53 interaction is still under investigation. HIN-200 proteins have been shown to regulate cell growth Lembo et al., 1995 Lembo et al., , 1998 Yan et al., 1999) and sensitivity to apoptosis (Koul et al., 1998) and stable expression of IFI 16 in 293 cells results in a decrease in cell proliferation and a delay in transition from G1 to S phase following cell cycle arrest by a thymidine block (RW Johnstone, unpublished observations). As IFI 16 and p202 can modulate transcriptional activation by p53 it can be hypothesized that it is through this mechanism that HIN-200 induce their eects on the cell cycle. As many of the studies were performed in cell lines that contain functionally inactive p53, wild type p53 is not essential for this function. However, expression of a key downstream target gene of p53, the CDK inhibitor p21 waf1/Cip1 , was induced in Saos-2 cells (p53 null) whose growth was inhibited following expression of p202 . Thus it is clear that while HIN-200 proteins can regulate cell proliferation, p53 may not be necessary for this function. However the downstream genes in the pathway leading to p53-mediated cell cycle arrest (i.e. p21 waf1/Cip1 ) may be regulated in a p53-independent manner.
IFI 16 joins a growing list of proteins that has inherent transcriptional regulatory functions and can modulate the gene regulatory functions of other proteins. That IFI 16, a transcriptional repressor, can augment transactivation mediated by p53 is not unprecedented. Transcriptional repressors such as YY1 (Shi et al., 1997) and WT1 (Wang et al., 1993) can activate or repress transcription depending on the promoter context and co-expression of cellular and/or viral proteins. The precise mechanism(s) involved in the regulatory function of IFI 16 on p53 have still yet to be fully dissected. Plabelled oligonucleotide containing consensus p53 binding sites to form a speci®c complex. Unlabelled competitor oligonucleotides (500-fold excess) containing either wild type p53 consensus sites (wtp53) or point mutations within the p53 sites that abolish p53 binding (mutp53) were added as indicated by + or 7 signs on the top. Supershift experiments were performed with either an a-IFI 16 monoclonal antibody or isotype control a-granzyme B (GzB) as indicated. The p53/DNA complex is indicated by an arrow on the right Treatment of cells with IFNs has been demonstrated to cause an increase in wild type p53 activity (Arany et al., 1996) . In addition to IFI 16, a number of other IFN-inducible proteins such as the PKR (Cuddihy et al., 1999) and PKC (Hupp et al., 1993) kinases, can directly bind to p53 and enhance p53-mediated transcriptional activation. Furthermore, the interferon inducible transcription factor IRF-1 has been shown to functionally synergise with p53 (Tanaka et al., 1996) . However, IFNs, can regulate proliferation and death in cells that contain functionally inactive, or are absent in, p53 (Subramanium and Johnson, 1997) and addition of IFN-g to p53 null cells can still result in an increase in the levels of p21 waf1/Cip1 (Hobeika et al., 1999) . Clearly the molecular pathways leading to IFN-mediated cell death and cell cycle arrest have not yet been completely de®ned. Our data and the studies of others (Hupp et al., 1993; Datta et al., 1996; Tanaka et al., 1996; Cuddihy et al., 1999) demonstrate a functional link between interferon-inducible cellular genes and the transcriptional activities of p53. It now remains to determine the importance of these ®ndings in a physiological context and to de®ne the molecular pathways that may be aected by p53 following exposure of cells to IFN.
Interferons are multifunctional cytokines that can regulate cell growth and survival by increasing or decreasing expression of cellular genes whose gene products either directly or indirectly mediate biological However there is now strong evidence predicting that this will indeed be the case.
Materials and methods
Plasmids
The plasmids used were as described previously: p13RE DIST/PROX reporter construct containing a CAT reporter gene with p53 consensus sequences upstream and downstream of the minimal E1b promoter; pE1bTATA control plasmid without the p53 sites (Stenger et al., 1994) ; pWWLUC containing a 2.4 Kb segment from the p21Waf/ Cip1 gene with a p53-binding site; pDMLUC which contains the p21Waf1/Cip1 promoter with the p53 binding site deleted (El-Deiry et al., 1993) ; pRcCMV-IFI 16 (Johnstone et al., 1998a) ; GST-IFI 16 (1 ± 729); ; (477 ± 729) (Johnstone et al., 1998b) ; and GST-IFI 16 (1 ± 159) (Dawson and Trapani, 1995) were described previously. pRcCMV-IFI 16 (1 ± 153) and pRcCMV-IFI 16 (1 ± 476) were constructed by digesting IFI 16 cDNA with KpnI and PstI and KpnI and PvuII respectively and cloning into the pRcCMV vector (Invitrogen). GST-IFI 16 (155 ± 476) was constructed by digesting IFI 16 cDNA with PstI and PvuII and cloning in frame into the pGex4T1 vector (Promega, Madison, WI, USA). The GST fusion proteins containing full length wild type human p53 and p53 deletion mutants encompassing amino acids 1 ± 160, 160 ± 318, 319 ± 393 (Chen et al., 1993) , 319 ± 362, 319 ± 337 and 362 ± 393 were also as described (Cuddihy et al, 1999) . pGEX-6P-1-p53 containing full length wild type human p53 downstream of the PreScission protease site (Lambert et al., 1998) . pSP72-p53 was kindly provided by Dr Phil Hinds (Harvard Medical School, Boston MA, USA).
Cells and transfections
293 cells were grown in Dulbecco's modi®ed Eagle medium (DMEM) supplemented with 10% heat inactivated foetal calf serum. The cells were transfected by the calcium phosphate precipitation method (Shi et al., 1991) or using FUGENE transfection reagent (Boehringer Mannheim). The total amount of DNA was adjusted with the plasmid pSP72 to be identical for each transfection. Cells were harvested 48 h after transfection. All transfection assays were carried out with at least two independent DNA preparations and were repeated between three and ®ve times. Daudi and Molt-4 cells were grown in RPMI 1640 medium supplemented with 10% heat inactivated foetal calf serum.
CAT and luciferase assays
Whole cell extracts were prepared from transfected cells. CAT activity was assayed as described (Shi et al., 1991) and quantitated with a phosphorimager (Molecular Dynamics, Sunnyvale, CA, USA). Appropriate amounts of cell extracts were used to measure CAT activity to ensure that the assays were performed within linear range. Luciferase assays were performed using the Luciferase Assay System according to manufacturers instructions (Promega, Madison, WI, USA).
Immunoprecipitation/Western blotting assays
Cells were lysed in lysis buer [25 mm HEPES (pH 7.0), 0.25 M NaCl, 2.5 mM EDTA, 0.5 mM DTT, 10 mg/ml leupeptin, 1 mg/ml pepstatin A, 2 mM phenylmethylsulphonyl uoride and 0.1% NP-40] for 30 min on ice. Extracts were incubated with antibodies overnight and immune complexes were collected with protein A-Sepharose beads at 48C for 1 h. The beads were washed eight times with lysis buer and the proteins eluted with Laemmli sample buer. Protein were separated by electrophoresis through a 10% polyacrylamide gel, transferred onto Immobilon PVDF membrane (Millipore, Bedford, MA, USA) and probed with monoclonal IFI 16 antibody (Dawson and Trapani, 1995) . Blots were incubated with HRP rabbit-mouse antibody (DAKO, Glostrup, Denmark) and immunoreactive proteins were visualized by chemiluminescence (Amersham, Buckinghamshire, UK).
Analysis of IFI 16 and p53 interactions with GST fusion proteins
GST fusion proteins were puri®ed as described (Kaelin Jr. et al., 1991) and the yield of each protein was determined by SDS ± PAGE analysis and Coomassie blue staining. GST proteins bound to glutathione-agarose beads (Sigma, St. Louis, MO, USA) were washed twice in NET-50 (20 mM Tris pH 8.0, 1 mM EDTA, 50 mM NaCl) for 15 min at room temperature and were incubated in 200 ml binding buer [25 mM HEPES pH 7.5, 12.5 mM MgCl 2 , 20% glycerol, 0.1% NP-40, 150 mM KCl, 1 mM dithiothreitol (DTT), 150 mg/ml bovine serum albumin (BSA), 200 mg/ml ethidium bromide (EtBr)] for 10 min at room temperature. In vitro transcription/translation reactions (Promega, Madison, WI, USA) containing [ 35 S]methionine (1175 Ci/mmol) were programmed with pSP72-p53 or pRcCMV-IFI 16 and 5 ml was incubated with immobilized GST-fusion proteins for 1 h at room temperature as indicated. The beads were washed ®ve times with 1 ml washing buer (20 mM Tris pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40, 200 mg/ml EtBr). Bound proteins were eluted with Laemmli sample buer, separated through a 10% SDS-polycarylamide gel and visualized by autoradiography.
Recombinant wild type p53 was obtained by producing GST-p53 from the pGEX-6P-1-p53 vector as above and cleaving o the GST moiety using the PreScission protease (Amersham Pharmacia Biotech) according to the manufacturers instructions. Recombinant p53 was incubated for 1 h at room temperature with GST-IFI 16 or GST alone in 200 ml binding buer. Beads were washed ®ve times with 1 ml washing buer, separated by electrophoresis through a 10% polyacrylamide gel, transferred onto Immobilon PVDF membrane (Millipore, Bedford, MA, USA) and probed with monoclonal anti p53 antibody DO-1 (Santa Cruz Biotechnology, CA, USA). Blots were incubated with HRP rabbitmouse antibody (DAKO, Glostrup, Denmark) and immunoreactive proteins were visualized by chemiluminescence (Amersham, Buckinghamshire, UK).
Immunofluorescence microscopy
Cells were resuspended in PBS supplemented with 5% BSA for cytospin slide preparation. Cells were ®xed in 2% paraformaldehyde, 0.01 M sodium periodate. 0.075 M Llysine, 0.037 M sodium phosphate buer as described (McLean and Nakane, 1974) . Slides were then incubated in rabbit anti-IFI 16 polyclonal antiserum and/or monoclonal anti-p53 antibody DO-1 (Santa Cruz Biotechnology, CA, USA) or control antibodies. Bound antibody was detected with FITC-conjugated anti-rabbit (Silenus, Melbourne, Australia) or Alexa-conjugated anti-mouse (Molecular Probes, Eugene, OR, USA) immunoglobulin. Slides were washed in PBS, mounted with coverslips and examined for uorescence.
Gel shift assays
Gel shift assays were performed using radiolabelled oligonucleotides containing either a consensus wild type p53 binding site derived from the p21 waf1/Cip1 promoter (wtp53 5'-GCCGAATTCGAACATGTCCGAACATGTT-GAGATCT-GCC-3') or a mutated p53 binding site (mutp53 5'-GCCGAATTCGAAAATTTCCGAATCCTTTGAGATC -TGCC') and were essentially performed as described previously (Gu and Roeder, 1997) . Supershifts were performed using anti-IFI 16 monoclonal antibody (Dawson and Trapani, 1995) or anti-granzyme B monoclonal antibody (Trapani et al., 1993) as an isotype control.
